Better characterization, diagnosis of insignificant prostate cancer

The full text of a “consensus” review entitled “The contemporary concept of significant versus insignificant prostate cancer” has just been published on line in European Urology. The authors include opinion-leaders from the USA, France, Italy, Germany, Sweden and Canada. … READ MORE …

What is the risk of NOT treating PSA-detected prostate cancer?

A new article in the May issue of Cancer Epidemiology, Biomarkers and Prevention appears to be a first attempt to project population-based probabilities of the occurrence of clinically significant prostate cancer among men who are diagnosed with prostate cancer but who receive no treatment. … READ MORE …

Prostate cancer news update: Tuesday, August 19

Recent publications reported on today include:

  • Demonstration of the validity of the Epstein criteria in defining pathologically insignificant prostate cancer
  • A review of the value of sildenafil (Viagra) and similar products in treatment of erectile dysfunction among prostate cancer patients
  • A review of the significance of “gene fusion” and its relevance in prostate cancer … READ MORE …

All the prostate cancer news for Friday, August 8

Today’s news items all focus on issues that are closely connected to the recent and controversial  guidelines issued by the US Preventive Services Task Force:

  • The accuracy of current methods for predicting the likelihood of clinically insignificant (indolent) prostate cancer
  • The management of patients found to have incidental prostate cancer on treatment for benign prostatic hyperplasia (BPH), and
  • The risks of overtreatment of men in their 70s and 80s after a diagnosis of prostate cancer … READ MORE …